![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Impax Receives Final FDA Approval for Generic Depakote Tablets
Impax Receives Final FDA Approval for Generic Depakote Tablets
May 7, 2009
Impax Laboratories, Inc. confirmed that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company’s Abbreviated New Drug Application (ANDA) for generic version of Depakote (divalproex ER) 250mg Extended-release Tablets.
MSN
MSN
Upcoming Events
-
21Oct